Novartis International Pharmaceutical AG
Company Overview
Management
Hans Reinhardt
Ehrenkirchen, DE
Chairperson of the board
Joint signing authority (any two to sign)
Dr. Bradner
Weston, US
Member of the board
Joint signing authority (any two to sign)
Harry Kirsch
Therwil
Member of the board
Joint signing authority (any two to sign)
Katja Roth Pellanda
Basel
Secretary (non-member of the board)
Joint signing authority (any two to sign)
Heike Bitzer
Lörrach, DE
Joint signing authority (any two to sign)
Bertrand Bugnon
Belfaux
Joint signing authority (any two to sign)
Felix Eichhorn
Basel
Joint signing authority (any two to sign)
Alisa Harbin
Reinach
Joint signing authority (any two to sign)
Riccarda Racine
Riehen
Joint signing authority (any two to sign)
Christian Rehm
Muttenz
Joint signing authority (any two to sign)
Theo Straumann
Seewen
Joint signing authority (any two to sign)
Stefan Thommen
Ramlinsburg
Joint signing authority (any two to sign)
Daniel Weiss
Biel-Benken
Joint signing authority (any two to sign)
Thomas Arnet
Arlesheim
Joint signing authority (any two to sign)
Robert Karsunky
Bourg-en-Lavaux
Joint signing authority (any two to sign)
Christopher Meyer
Oberwil
Joint signing authority (any two to sign)
Simone Pfirter
Pratteln
Joint signing authority (any two to sign)
Beat Buser
Allschwil
Joint signing authority (any two to sign)
Robert Stanley
Basel
Joint signing authority (any two to sign)
Shannon Klinger
Basel
Member of the board
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 2658 | 08.05.2020 | 92 | 13.05.2020 | 1004888631 |
| 2 | 2737 | 15.05.2019 | 96 | 20.05.2019 | 1004633658 |
| 3 | 1409 | 06.03.2019 | 48 | 11.03.2019 | 1004584556 |
| 4 | 5015 | 04.09.2018 | 173 | 07.09.2018 | 1004451353 |
| 5 | 3960 | 13.07.2018 | 137 | 18.07.2018 | 4366641 |
| 6 | 2339 | 23.04.2018 | 80 | 26.04.2018 | 4195891 |
| 7 | 4711 | 24.08.2017 | 166 | 29.08.2017 | 3720231 |
| 8 | 3866 | 06.07.2017 | 132 | 11.07.2017 | 3637071 |
| 9 | 1753 | 24.03.2017 | 62 | 29.03.2017 | 3433001 |
| 10 | 6856 | 08.12.2016 | 242 | 13.12.2016 | 3218845 |
Company Purpose
Zweck der Gesellschaft ist die Beteiligung an Unternehmen irgendwelcher Art. Die Gesellschaft ist berechtigt, Liegenschaften und Immaterialgüterrechte im In- und Ausland zu erwerben, zu belasten, zu verwerten und zu verkaufen. Die Gesellschaft kann daneben Leistungen in der Forschung, der Fabrikation und des Vertriebs im Bereich von pharmazeutischen, chemischen, medizinisch-technischen, biotechnologischen und verwandten Produkten sowie von damit im Zusammenhang stehenden Dienstleistungen erbringen.